Alpha-GPC, a choline-rich supplement, enhances brain health by increasing acetylcholine, with potential applications in ...

Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...

A new study from the University of East Anglia has found that long-term use of certain antidepressants may increase the risk of dementia, even if taken up to 20 years before a diagnosis. The study ...

Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 ...

When used responsibly botulinum toxin is very safe, but patients should be especially vigilant about cosmetic treatments done ...

The vagus nerve does it all—tells your lungs to breathe, controls your heart rate, and even forms the foundation for a whole ...

Are concerns about sleeping pills being linked to dementia based on evidence? Many people need help getting to, or staying, ...

Examples of drugs in this family are phenobarbital and butalbital. Side effects of DMAE may be more likely if it's taken with other drugs that increase acetylcholine levels in the body (cholinergic ...

BURLINGTON, Mass. - Neuphoria Therapeutics Inc. (NASDAQ:NEUP), a biotechnology firm focused on neuropsychiatric treatments with a market capitalization of $7.27 million, is set to receive a $15 ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up the portfolio ahead of its merger with TuHURA ...

Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), a late-stage biotechnology developing impactful treatments for neuropsychiatric ...